Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 192 of 261 entries
Sorted by: Best Match Show Resources per page
A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells.

Science advances

Bozza M, De Roia A, Correia MP, Berger A, Tuch A, Schmidt A, Zörnig I, Jäger D, Schmidt P, Harbottle RP.
PMID: 33853779
Sci Adv. 2021 Apr 14;7(16). doi: 10.1126/sciadv.abf1333. Print 2021 Apr.

The compelling need to provide adoptive cell therapy (ACT) to an increasing number of oncology patients within a meaningful therapeutic window makes the development of an efficient, fast, versatile, and safe genetic tool for creating recombinant T cells indispensable....

Cite
Bozza M, De Roia A, Correia MP, et al. A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells. Sci Adv. 2021;7(16)doi: 10.1126/sciadv.abf1333.
Bozza, M., De Roia, A., Correia, M. P., Berger, A., Tuch, A., Schmidt, A., Zörnig, I., Jäger, D., Schmidt, P., & Harbottle, R. P. (2021). A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells. Science advances, 7(16), . https://doi.org/10.1126/sciadv.abf1333
Bozza, Matthias, et al. "A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells." Science advances vol. 7,16 (2021). doi: https://doi.org/10.1126/sciadv.abf1333
Bozza M, De Roia A, Correia MP, Berger A, Tuch A, Schmidt A, Zörnig I, Jäger D, Schmidt P, Harbottle RP. A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells. Sci Adv. 2021 Apr 14;7(16). doi: 10.1126/sciadv.abf1333. Print 2021 Apr. PMID: 33853779; PMCID: PMC8046366.
Copy Download .nbib Format: NLM
Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review.

Advances in integrative medicine

Schloss J, Lauche R, Harnett J, Hannan N, Brown D, Greenfield T, Steel A.
PMID: 32837893
Adv Integr Med. 2020 Dec;7(4):187-191. doi: 10.1016/j.aimed.2020.07.008. Epub 2020 Jul 31.

BRIEF OVERVIEW: Current evidence from published systematic reviews indicate that oral intake of vitamin C may assist with symptoms of acute viral respiratory infections (ARI) by reducing fever and chills, relieving chest pain and assist in reducing symptoms of...

Cite
Schloss J, Lauche R, Harnett J, et al. Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review. Adv Integr Med. 2020;7(4):187-191doi: 10.1016/j.aimed.2020.07.008.
Schloss, J., Lauche, R., Harnett, J., Hannan, N., Brown, D., Greenfield, T., & Steel, A. (2020). Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review. Advances in integrative medicine, 7(4), 187-191. https://doi.org/10.1016/j.aimed.2020.07.008
Schloss, Janet, et al. "Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review." Advances in integrative medicine vol. 7,4 (2020): 187-191. doi: https://doi.org/10.1016/j.aimed.2020.07.008
Schloss J, Lauche R, Harnett J, Hannan N, Brown D, Greenfield T, Steel A. Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: A rapid review. Adv Integr Med. 2020 Dec;7(4):187-191. doi: 10.1016/j.aimed.2020.07.008. Epub 2020 Jul 31. PMID: 32837893; PMCID: PMC7393036.
Copy Download .nbib Format: NLM
Author Correction: A massive core for a cluster of galaxies at a redshift of 4.3.

Nature

Miller TB, Chapman SC, Aravena M, Ashby MLN, Hayward CC, Vieira JD, Weiß A, Babul A, Béthermin M, Bradford CM, Brodwin M, Carlstrom JE, Chen CC, Cunningham DJM, De Breuck C, Gonzalez AH, Greve TR, Harnett J, Hezaveh Y, Lacaille K, Litke KC, Ma J, Malkan M, Marrone DP, Morningstar W, Murphy EJ, Narayanan D, Pass E, Perry R, Phadke KA, Rennehan D, Rotermund KM, Simpson J, Spilker JS, Sreevani J, Stark AA, Strandet ML, Strom AL.
PMID: 29930351
Nature. 2018 Sep;561(7721):E2. doi: 10.1038/s41586-018-0285-x.

Change history: In this Letter, the Acknowledgements section should have included the following sentence: "The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc.". This omission has been...

Cite
Miller TB, Chapman SC, Aravena M, et al. Author Correction: A massive core for a cluster of galaxies at a redshift of 4.3. Nature. 2018;561(7721):E2doi: 10.1038/s41586-018-0285-x.
Miller, T. B., Chapman, S. C., Aravena, M., Ashby, M. L. N., Hayward, C. C., Vieira, J. D., Weiß, A., Babul, A., Béthermin, M., Bradford, C. M., Brodwin, M., Carlstrom, J. E., Chen, C. C., Cunningham, D. J. M., De Breuck, C., Gonzalez, A. H., Greve, T. R., Harnett, J., Hezaveh, Y., Lacaille, K., Litke, K. C., Ma, J., Malkan, M., Marrone, D. P., Morningstar, W., Murphy, E. J., Narayanan, D., Pass, E., Perry, R., Phadke, K. A., Rennehan, D., Rotermund, K. M., Simpson, J., Spilker, J. S., Sreevani, J., Stark, A. A., Strandet, M. L., & Strom, A. L. (2018). Author Correction: A massive core for a cluster of galaxies at a redshift of 4.3. Nature, 561(7721), E2. https://doi.org/10.1038/s41586-018-0285-x
Miller, T B, et al. "Author Correction: A massive core for a cluster of galaxies at a redshift of 4.3." Nature vol. 561,7721 (2018): E2. doi: https://doi.org/10.1038/s41586-018-0285-x
Miller TB, Chapman SC, Aravena M, Ashby MLN, Hayward CC, Vieira JD, Weiß A, Babul A, Béthermin M, Bradford CM, Brodwin M, Carlstrom JE, Chen CC, Cunningham DJM, De Breuck C, Gonzalez AH, Greve TR, Harnett J, Hezaveh Y, Lacaille K, Litke KC, Ma J, Malkan M, Marrone DP, Morningstar W, Murphy EJ, Narayanan D, Pass E, Perry R, Phadke KA, Rennehan D, Rotermund KM, Simpson J, Spilker JS, Sreevani J, Stark AA, Strandet ML, Strom AL. Author Correction: A massive core for a cluster of galaxies at a redshift of 4.3. Nature. 2018 Sep;561(7721):E2. doi: 10.1038/s41586-018-0285-x. PMID: 29930351.
Copy Download .nbib Format: NLM
Delaware Faces Immunization Challenges Head-on.

Delaware journal of public health

Talbott J, Hess P.
PMID: 34467023
Dela J Public Health. 2019 May 28;5(2):6-10. doi: 10.32481/djph.2019.05.003. eCollection 2019 May.

This article explores the recent history of under immunized vaccine preventable diseases, along with recent outbreaks and how the Delaware Division of Public Health has responded to each. Delaware's vaccination efforts for children have achieved high coverage rates for...

Cite
Talbott J, Hess P. Delaware Faces Immunization Challenges Head-on. Dela J Public Health. 2019;5(2):6-10doi: 10.32481/djph.2019.05.003.
Talbott, J., & Hess, P. (2019). Delaware Faces Immunization Challenges Head-on. Delaware journal of public health, 5(2), 6-10. https://doi.org/10.32481/djph.2019.05.003
Talbott, Jim, and Hess, Paul. "Delaware Faces Immunization Challenges Head-on." Delaware journal of public health vol. 5,2 (2019): 6-10. doi: https://doi.org/10.32481/djph.2019.05.003
Talbott J, Hess P. Delaware Faces Immunization Challenges Head-on. Dela J Public Health. 2019 May 28;5(2):6-10. doi: 10.32481/djph.2019.05.003. eCollection 2019 May. PMID: 34467023; PMCID: PMC8396752.
Copy Download .nbib Format: NLM
Delaware's HPV vaccination rates rise with evidence-based intervention implementation.

Delaware journal of public health

Gruss L, Saul L, Toborowski S, Talbott J, Hess P.
PMID: 34467134
Dela J Public Health. 2020 Aug 13;6(3):62-66. doi: 10.32481/djph.2020.08.018. eCollection 2020 Aug.

No abstract available.

Cite
Gruss L, Saul L, Toborowski S, et al. Delaware's HPV vaccination rates rise with evidence-based intervention implementation. Dela J Public Health. 2020;6(3):62-66doi: 10.32481/djph.2020.08.018.
Gruss, L., Saul, L., Toborowski, S., Talbott, J., & Hess, P. (2020). Delaware's HPV vaccination rates rise with evidence-based intervention implementation. Delaware journal of public health, 6(3), 62-66. https://doi.org/10.32481/djph.2020.08.018
Gruss, Lisa, et al. "Delaware's HPV vaccination rates rise with evidence-based intervention implementation." Delaware journal of public health vol. 6,3 (2020): 62-66. doi: https://doi.org/10.32481/djph.2020.08.018
Gruss L, Saul L, Toborowski S, Talbott J, Hess P. Delaware's HPV vaccination rates rise with evidence-based intervention implementation. Dela J Public Health. 2020 Aug 13;6(3):62-66. doi: 10.32481/djph.2020.08.018. eCollection 2020 Aug. PMID: 34467134; PMCID: PMC8389098.
Copy Download .nbib Format: NLM
Rural Community Perceptions and Interests in Pharmacogenomics.

Healthcare (Basel, Switzerland)

Stegelmeier J, Nartker C, Barnes C, Rayo H, Hoover R, Boyle J, O'Connor S, Barrott J.
PMID: 32516951
Healthcare (Basel). 2020 Jun 05;8(2). doi: 10.3390/healthcare8020159.

Pharmacogenomics testing is a rapidly expanding field with increasing importance to individualized patient care. However, it remains unclear whether the general public in rural areas would be willing to engage in this service. The objective of this survey was...

Cite
Stegelmeier J, Nartker C, Barnes C, et al. Rural Community Perceptions and Interests in Pharmacogenomics. Healthcare (Basel). 2020;8(2)doi: 10.3390/healthcare8020159.
Stegelmeier, J., Nartker, C., Barnes, C., Rayo, H., Hoover, R., Boyle, J., O'Connor, S., & Barrott, J. (2020). Rural Community Perceptions and Interests in Pharmacogenomics. Healthcare (Basel, Switzerland), 8(2), . https://doi.org/10.3390/healthcare8020159
Stegelmeier, John, et al. "Rural Community Perceptions and Interests in Pharmacogenomics." Healthcare (Basel, Switzerland) vol. 8,2 (2020). doi: https://doi.org/10.3390/healthcare8020159
Stegelmeier J, Nartker C, Barnes C, Rayo H, Hoover R, Boyle J, O'Connor S, Barrott J. Rural Community Perceptions and Interests in Pharmacogenomics. Healthcare (Basel). 2020 Jun 05;8(2). doi: 10.3390/healthcare8020159. PMID: 32516951; PMCID: PMC7348789.
Copy Download .nbib Format: NLM
Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine.

Postepy dermatologii i alergologii

Nowicki RJ, Trzeciak M, Rudnicka L, Szepietowski J, Kulus M, Kupczyk M, Mastalerz-Migas A, Peregud-Pogorzelski J, Jahnz-Różyk K, Narbutt J, Czarnecka-Operacz M, Czajkowski R, Grubska-Suchanek E, Krasowska D, Kręcisz B, Kowalewski C, Lesiak A, Olszewska M, Samochocki Z, Śpiewak R, Wilkowska A.
PMID: 33239998
Postepy Dermatol Alergol. 2020 Oct;37(5):617-624. doi: 10.5114/ada.2020.100496. Epub 2020 Nov 07.

Atopic dermatitis (AD) is secondary to genetic, immunological and microbiological disorders as well as epidermal barrier defects, which are the main targets of therapy. The disease proceeds with periodic exacerbations. Its development and course are influenced by numerous environmental...

Cite
Nowicki RJ, Trzeciak M, Rudnicka L, et al. Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine. Postepy Dermatol Alergol. 2020;37(5):617-624doi: 10.5114/ada.2020.100496.
Nowicki, R. J., Trzeciak, M., Rudnicka, L., Szepietowski, J., Kulus, M., Kupczyk, M., Mastalerz-Migas, A., Peregud-Pogorzelski, J., Jahnz-Różyk, K., Narbutt, J., Czarnecka-Operacz, M., Czajkowski, R., Grubska-Suchanek, E., Krasowska, D., Kręcisz, B., Kowalewski, C., Lesiak, A., Olszewska, M., Samochocki, Z., Śpiewak, R., & Wilkowska, A. (2020). Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine. Postepy dermatologii i alergologii, 37(5), 617-624. https://doi.org/10.5114/ada.2020.100496
Nowicki, Roman J, et al. "Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine." Postepy dermatologii i alergologii vol. 37,5 (2020): 617-624. doi: https://doi.org/10.5114/ada.2020.100496
Nowicki RJ, Trzeciak M, Rudnicka L, Szepietowski J, Kulus M, Kupczyk M, Mastalerz-Migas A, Peregud-Pogorzelski J, Jahnz-Różyk K, Narbutt J, Czarnecka-Operacz M, Czajkowski R, Grubska-Suchanek E, Krasowska D, Kręcisz B, Kowalewski C, Lesiak A, Olszewska M, Samochocki Z, Śpiewak R, Wilkowska A. Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine. Postepy Dermatol Alergol. 2020 Oct;37(5):617-624. doi: 10.5114/ada.2020.100496. Epub 2020 Nov 07. PMID: 33239998; PMCID: PMC7675073.
Copy Download .nbib Format: NLM
Overexpression of cathepsin K and vascular endothelial growth factor in chronic venous ulcerations.

Postepy dermatologii i alergologii

Kolano P, Bednarski IA, Lesiak A, Skibińska M, Stasikowska-Kanicka O, Danilewicz M, Narbutt J.
PMID: 32489360
Postepy Dermatol Alergol. 2020 Apr;37(2):234-239. doi: 10.5114/ada.2020.94840. Epub 2020 May 06.

INTRODUCTION: Chronic venous disease (CVD) is a disabling condition affecting about 1% to 3% of the general population. Besides varicose veins, CVD can result also in the formation of severe skin lesions, especially venous ulcerations (VU). The exact mechanism...

Cite
Kolano P, Bednarski IA, Lesiak A, et al. Overexpression of cathepsin K and vascular endothelial growth factor in chronic venous ulcerations. Postepy Dermatol Alergol. 2020;37(2):234-239doi: 10.5114/ada.2020.94840.
Kolano, P., Bednarski, I. A., Lesiak, A., Skibińska, M., Stasikowska-Kanicka, O., Danilewicz, M., & Narbutt, J. (2020). Overexpression of cathepsin K and vascular endothelial growth factor in chronic venous ulcerations. Postepy dermatologii i alergologii, 37(2), 234-239. https://doi.org/10.5114/ada.2020.94840
Kolano, Paweł, et al. "Overexpression of cathepsin K and vascular endothelial growth factor in chronic venous ulcerations." Postepy dermatologii i alergologii vol. 37,2 (2020): 234-239. doi: https://doi.org/10.5114/ada.2020.94840
Kolano P, Bednarski IA, Lesiak A, Skibińska M, Stasikowska-Kanicka O, Danilewicz M, Narbutt J. Overexpression of cathepsin K and vascular endothelial growth factor in chronic venous ulcerations. Postepy Dermatol Alergol. 2020 Apr;37(2):234-239. doi: 10.5114/ada.2020.94840. Epub 2020 May 06. PMID: 32489360; PMCID: PMC7262799.
Copy Download .nbib Format: NLM
Ultraviolet Radiation and Chronic Inflammation-Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review.

Life (Basel, Switzerland)

Ciążyńska M, Olejniczak-Staruch I, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A.
PMID: 33917793
Life (Basel). 2021 Apr 08;11(4). doi: 10.3390/life11040326.

The process of skin carcinogenesis is still not fully understood. Both experimental and epidemiological evidence indicate that chronic inflammation is one of the hallmarks of microenvironmental-agent-mediated skin cancers and contributes to its development. Maintaining an inflammatory microenvironment is a...

Cite
Ciążyńska M, Olejniczak-Staruch I, Sobolewska-Sztychny D, et al. Ultraviolet Radiation and Chronic Inflammation-Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review. Life (Basel). 2021;11(4)doi: 10.3390/life11040326.
Ciążyńska, M., Olejniczak-Staruch, I., Sobolewska-Sztychny, D., Narbutt, J., Skibińska, M., & Lesiak, A. (2021). Ultraviolet Radiation and Chronic Inflammation-Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review. Life (Basel, Switzerland), 11(4), . https://doi.org/10.3390/life11040326
Ciążyńska, Magdalena, et al. "Ultraviolet Radiation and Chronic Inflammation-Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review." Life (Basel, Switzerland) vol. 11,4 (2021). doi: https://doi.org/10.3390/life11040326
Ciążyńska M, Olejniczak-Staruch I, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A. Ultraviolet Radiation and Chronic Inflammation-Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review. Life (Basel). 2021 Apr 08;11(4). doi: 10.3390/life11040326. PMID: 33917793; PMCID: PMC8068112.
Copy Download .nbib Format: NLM
Building Resilience During COVID-19: Recommendations for Adapting the DREAM Program - Live Edition to an Online-Live Hybrid Model for In-Person and Virtual Classrooms.

Frontiers in psychology

Parrott J, Armstrong LL, Watt E, Fabes R, Timlin B.
PMID: 34322055
Front Psychol. 2021 Jul 12;12:647420. doi: 10.3389/fpsyg.2021.647420. eCollection 2021.

In standard times, approximately 20% of children and youth experience significant emotional, behavioral, or social challenges. During COVID-19, however, over

Cite
Parrott J, Armstrong LL, Watt E, et al. Building Resilience During COVID-19: Recommendations for Adapting the DREAM Program - Live Edition to an Online-Live Hybrid Model for In-Person and Virtual Classrooms. Front Psychol. 2021;12:647420doi: 10.3389/fpsyg.2021.647420.
Parrott, J., Armstrong, L. L., Watt, E., Fabes, R., & Timlin, B. (2021). Building Resilience During COVID-19: Recommendations for Adapting the DREAM Program - Live Edition to an Online-Live Hybrid Model for In-Person and Virtual Classrooms. Frontiers in psychology, 12647420. https://doi.org/10.3389/fpsyg.2021.647420
Parrott, Julia, et al. "Building Resilience During COVID-19: Recommendations for Adapting the DREAM Program - Live Edition to an Online-Live Hybrid Model for In-Person and Virtual Classrooms." Frontiers in psychology vol. 12 (2021): 647420. doi: https://doi.org/10.3389/fpsyg.2021.647420
Parrott J, Armstrong LL, Watt E, Fabes R, Timlin B. Building Resilience During COVID-19: Recommendations for Adapting the DREAM Program - Live Edition to an Online-Live Hybrid Model for In-Person and Virtual Classrooms. Front Psychol. 2021 Jul 12;12:647420. doi: 10.3389/fpsyg.2021.647420. eCollection 2021. PMID: 34322055; PMCID: PMC8311233.
Copy Download .nbib Format: NLM
Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review.

BMJ open

Macpherson K, Cooper K, Harbour J, Mahal D, Miller C, Nairn M.
PMID: 35017239
BMJ Open. 2022 Jan 11;12(1):e050979. doi: 10.1136/bmjopen-2021-050979.

OBJECTIVE: To explore the experiences of people living with long COVID and how they perceive the healthcare services available to them.DESIGN: Qualitative systematic review.DATA SOURCES: Electronic literature searches of websites, bibliographic databases and discussion forums, including PubMed LitCovid, Proquest...

Cite
Macpherson K, Cooper K, Harbour J, et al. Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open. 2022;12(1):e050979doi: 10.1136/bmjopen-2021-050979.
Macpherson, K., Cooper, K., Harbour, J., Mahal, D., Miller, C., & Nairn, M. (2022). Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ open, 12(1), e050979. https://doi.org/10.1136/bmjopen-2021-050979
Macpherson, Karen, et al. "Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review." BMJ open vol. 12,1 (2022): e050979. doi: https://doi.org/10.1136/bmjopen-2021-050979
Macpherson K, Cooper K, Harbour J, Mahal D, Miller C, Nairn M. Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open. 2022 Jan 11;12(1):e050979. doi: 10.1136/bmjopen-2021-050979. PMID: 35017239; PMCID: PMC8753091.
Copy Download .nbib Format: NLM
Volatile organic compounds of .

Biological control : theory and applications in pest management

Hummadi EH, Dearden A, Generalovic T, Clunie B, Harrott A, Cetin Y, Demirbek M, Khoja S, Eastwood D, Dudley E, Hazir S, Touray M, Ulug D, Hazal Gulsen S, Cimen H, Butt T.
PMID: 33814871
Biol Control. 2021 Apr;155:104527. doi: 10.1016/j.biocontrol.2020.104527.

The entomopathogenic fungus (EPF)

Cite
Hummadi EH, Dearden A, Generalovic T, et al. Volatile organic compounds of . Biol Control. 2021;155:104527doi: 10.1016/j.biocontrol.2020.104527.
Hummadi, E. H., Dearden, A., Generalovic, T., Clunie, B., Harrott, A., Cetin, Y., Demirbek, M., Khoja, S., Eastwood, D., Dudley, E., Hazir, S., Touray, M., Ulug, D., Hazal Gulsen, S., Cimen, H., & Butt, T. (2021). Volatile organic compounds of . Biological control : theory and applications in pest management, 155104527. https://doi.org/10.1016/j.biocontrol.2020.104527
Hummadi, Esam H, et al. "Volatile organic compounds of ." Biological control : theory and applications in pest management vol. 155 (2021): 104527. doi: https://doi.org/10.1016/j.biocontrol.2020.104527
Hummadi EH, Dearden A, Generalovic T, Clunie B, Harrott A, Cetin Y, Demirbek M, Khoja S, Eastwood D, Dudley E, Hazir S, Touray M, Ulug D, Hazal Gulsen S, Cimen H, Butt T. Volatile organic compounds of . Biol Control. 2021 Apr;155:104527. doi: 10.1016/j.biocontrol.2020.104527. PMID: 33814871; PMCID: PMC7923176.
Copy Download .nbib Format: NLM
Showing 181 to 192 of 261 entries